直接与间接嗓音治疗对儿童声带小结的随机临床试验
这项多中心随机临床试验纳入114名6至10岁声带小结患儿,随机接受直接或间接嗓音治疗8至12周。两组PVRQOL评分均较治疗前显著改善,直接治疗组平均提高19.2分,间接治疗组提高14.7分,组间差异无统计学意义。两种疗法均能改善患儿嗓音相关生活质量。
要点
- 直接与间接嗓音治疗均显著改善声带小结患儿的PVRQOL评分。
- 直接治疗组PVRQOL平均提高19.2分,间接治疗组提高14.7分。
- 两组间临床意义改善比例差异无统计学意义。
核心结论
- 直接和间接嗓音治疗均能改善声带小结患儿的嗓音相关生活质量,两种方法间无显著差异。
研究设计与样本
- 多中心随机临床试验,纳入114名6至10岁声带小结患儿,随机分入直接或间接嗓音治疗组,治疗8至12周。
主要发现
- 直接治疗组PVRQOL平均提高19.2分,间接治疗组提高14.7分,差异为4.5(95.3% CI,-10.8至19.8)。
- 直接治疗组44人中27人(61%)达到临床意义改善,间接治疗组49人中26人(53%)达到,差异为8%(95% CI,-12至28)。
- 事后分层显示直接治疗对年长儿童(Cohen d=0.50)和后三分之二参与者(Cohen d=0.46)效果更明显。
- 同意复查的70名参与者中,31%(22/70)声带小结缩小,11%(8/70)完全消退。
临床怎么用
- 临床可选用直接或间接嗓音治疗改善声带小结患儿的嗓音相关生活质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Benign vocal fold nodules affect 12% to 22% of the pediatric population, and 95% of otolaryngologists recommend voice therapy as treatment. However, no randomized clinical trials that we are aware of have shown its benefits. OBJECTIVE: To determine the impact of voice therapy in children with vocal fold nodules according to pretherapy and posttherapy scores on the Pediatric Voice-Related Quality of Life (PVRQOL) survey; secondary objectives included changes in phonatory parameters. DESIGN, SETTING, AND PARTICIPANTS: For this multicenter randomized clinical trial, 114 children ages 6 to 10 years with vocal fold nodules, PVRQOL scores less than 87.5, and dysphonia for longer than 12 weeks were recruited from outpatient voice and speech clinics. This age range was identified because these patients have not experienced pubertal changes of the larynx, tolerate stroboscopy, and cooperate with voice therapy. Participants were blinded to treatment arm. INTERVENTIONS: Participants received either indirect or direct therapy for 8 to 12 weeks. Indirect therapy focused on education and discussion of voice principles, while direct treatment used the stimulus, response, antecedent paradigm. MAIN OUTCOMES AND MEASURES: The primary outcome measure was PVRQOL score change before and after treatment. Secondary phonatory measures were also compared. RESULTS: Overall, 114 children were recruited for study (mean [SD] age, 8 [1.4] years; 83 males [73%]); with 57 randomized to receive either indirect or direct therapy. Both direct and indirect therapy approaches showed significant differences in PVRQOL scores pretherapy to posttherapy. The mean increase in PVRQOL score for direct therapy was 19.2, and 14.7 for indirect therapy (difference, 4.5; 95.3% CI, -10.8 to 19.8). Of 44 participants in the direct therapy group, 27 (61%) achieved a clinically meaningful PVRQOL improvement, compared with 26 of 49 (53%) for indirect therapy (difference, 8%; 95% CI, -12 to 28). Post hoc stratification showed robust effects in the direct therapy group for older children (Cohen d = 0.50) and the latter two-thirds of participants (Cohen d = 0.46). Vocal fold nodules reduced in size in 31% (22 of 70) and completely resolved in 11% (8 of 70) of participants who consented to a second set of images after going through the recruitment process. CONCLUSIONS AND RELEVANCE: Both direct and indirect voice therapy improved voice-related quality of life in children with vocal fold nodules, although there was no significant difference between approaches. Future studies may focus upon which voice therapy approaches are effective in treating age-defined populations. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01255735.
引用
- Hartnick C, Ballif C, De Guzman V, et al. Indirect vs Direct Voice Therapy for Children With Vocal Nodules: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2018. PMID: 29270612. doi:10.1001/jamaoto.2017.2618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。